Here, we find that blockage of cAMP degradation by PDE inhibitors does not affect the growth of SmoM2-induced tumors, but activation of the Gαs-coupled ADORA2B can lead to reduced tumor burden and proliferation. The gene discussed is ADORA2B; the disease is neoplasm.